ArticleTherapeutic advances in endocrinology and metabolism2026

Associations of mortality and sepsis after GLP-1 receptor agonist initiation versus SGLT2 inhibitor or metformin initiation in people with HIV, overweight or obesity, and type 2 diabetes: A target trial emulation.

Yu-Nan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.